Category: Markets
Market analysis at the intersection of technology, capital flows, valuations, public equities and private funding.
-
Space Startup Funding Hits $20.8B as Infrastructure Bets Surge
Space startup funding hit a record $20.8 billion in Q3, with infrastructure investments driving the surge. Here’s what the shift means for the industry.
-
The AI Chip Sell-Off Is a Reality Check, Not a Crash
AI chip stocks tumbled as investors question the payoff timeline. Here’s what TSMC’s earnings and the sell-off reveal about the AI infrastructure buildout.
-
Skeleton Technologies Raises Billions to Power AI’s Dirty Secret
Skeleton Technologies hits unicorn status with a major raise, betting that supercapacitors can solve AI data centers’ growing power and grid problems.
-
Korea’s $1.4B Chip Bet Draws Foreign Startups
Foreign startups are chasing Korea’s $1.4B chip boom, drawn by subsidies, memory giants, and a push to build sovereign AI silicon.
-
The AI Trade Just Got Its First Real Stress Test
Australia’s biggest IPO in decades flopped, and the AI trade is feeling it. Here’s what the failure signals about investor nerves and the wider tech rally.
-
Chip Stocks Slip as AI Spending Fears Meet China Memory Threat
US chip stocks extend losses as China memory advances and AI spending jitters rattle investors. We unpack what’s really driving semiconductor market volatility.
-
Europe’s Deep-Tech Bet: Inside Czech IP Lab’s €50M Fund
Czech IP Lab Ventures raised €27M from the EIF toward a €50M deep-tech fund, signaling Europe’s push to commercialize hard science.
-
Baltimore VC Holds Steady as Chip Stocks Slide
Baltimore VC deal count held steady in Q3 even as capital concentrated at the top, mirroring a split startup market and a brutal week for chip stocks.
-
The Chip Rally Meets Its Reckoning as AI Spending Doubts Grow
Micron, SoftBank and ASML slide as Wall Street’s chip rout spreads, raising hard questions about whether the AI hardware boom can justify its own valuations.
-
A $36M Bet That Skin Sensors Beat the Needle
Ascensia’s $36M bet on needle-free glucose sensing shows how medtech, AI, and chip money are converging on continuous health monitoring.